Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2012-03-19 Declaration of Voting R…
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled 'METabolic EXplorer : information relative au nombre total de droits de vote et d'actions composant le capital' (Information relative to the total number of voting rights and shares comprising the capital). It explicitly references Article 223-16 of the AMF (Autorité des Marchés Financiers) general regulation and provides a breakdown of total shares and voting rights as of a specific date (29/02/2012). This content directly relates to the official declaration of voting rights and share capital structure, which aligns perfectly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a management change announcement.
2012-03-19 French
METabolic EXplorer au sein du parc Bio-XCell (Malaisie) : léger décalage dans le calendrier de construction
Regulatory Filings Classification · 95% confidence The document is a press release dated March 9, 2012, announcing a slight delay in the construction schedule of METabolic EXplorer's production plant in Malaysia due to engineering documentation issues and soil conditioning work by Bio-XCell. This type of announcement, detailing operational updates, strategic developments (expansion in Southeast Asia), and project timelines, is characteristic of general corporate news releases. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general corporate communication about operations and strategy, and does not fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), the most appropriate classification is the general Regulatory Filings category (RNS), which serves as a fallback for miscellaneous official announcements that are not covered by more specific codes. Given the content is a direct operational update, it is not an RPA, as it is the substantive news itself, not just an announcement of another report's publication.
2012-03-09 French
Point sur l'activité au 4ème trimestre 2011 ; Atteintes de nouveaux jalons techniques avec ROQUETTE, partenaire historique
Earnings Release Classification · 95% confidence The document is titled "METabolic EXplorer : Point sur l'activité au 4ème trimestre 2011" and provides a summary of commercial and financial updates specifically for the 4th quarter of 2011, including a small table showing quarterly revenue figures. This structure—a brief update on recent performance, often highlighting key metrics or milestones for a specific period shorter than a full year—is characteristic of an Earnings Release (ER) or an Interim Report (IR). Since it focuses on the *quarterly* activity summary and financial highlights (revenue table) rather than a comprehensive, audited report, it aligns best with the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It is too detailed for a simple Report Publication Announcement (RPA) but lacks the depth of a full Interim Report (IR) or Annual Report (10-K). The length (4481 chars) supports it being a summary announcement rather than a full report. Q4 2011
2012-02-16 French
Les résultats positifs des essais zootechniques initiés sur les volailles et les porcelets permettent d'envisager l'étape d'industrialisation du projet de la L-Méthionine développé sous licence exclus
Capital/Financing Update Classification · 95% confidence The document is a joint press release from METabolic EXplorer and ROQUETTE dated January 12, 2012, announcing major positive results from zootechnical trials for their bio-sourced L-Methionine project and stating that ROQUETTE is moving into the industrialization study phase. This type of announcement, detailing operational progress, test results, and next steps (like preparing regulatory dossiers), is characteristic of a corporate update or press release regarding business development, rather than a formal regulatory filing like a 10-K, an Earnings Release (ER), or a specific financial report (IR, AR). Since it is an announcement of significant business progress and partnership milestones, it fits best under the general category of a corporate announcement that doesn't strictly align with the other specific codes (like M&A, Capital Change, or Dividend). Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general corporate press release that communicates material, non-financial-statement-specific news, although 'MDA' (Management Reports) or 'LTR' (Legal/Regulatory updates, as they mention preparing regulatory dossiers) could be considered. However, RNS serves as the best general regulatory/corporate announcement category when a more specific code is not applicable. The document is not short enough to trigger the RPA rule, as it contains substantial narrative content.
2012-01-12 French
The positive results of zootechnical tests initiated on poultry and piglets pave the way to the industrialisation phase of the L-Methionine project developed under an exclusive license
Regulatory Filings Classification · 95% confidence The document is explicitly titled as a "press release" from two companies (METabolic EXplorer and ROQUETTE) announcing a major step forward in their L-Methionine project, including positive zootechnical test results and the initiation of the regulatory approvals process and industrialization study. This is not a formal regulatory filing like a 10-K, a comprehensive quarterly report (IR), or a specific shareholder document (DEF 14A, DVA). It is an announcement of business progress and results, which most closely aligns with an Earnings Release (ER) if it were quarterly results, or a general Regulatory Filing (RNS) if it doesn't fit elsewhere. Since it details significant operational and development milestones rather than just financial figures, and it is structured as a standard press release, it fits best under the general Regulatory Filings (RNS) category, as it is a public announcement of material information that doesn't fit the more specific operational/financial codes. Given the context of financial reporting databases, press releases announcing significant operational milestones often fall into RNS if they aren't explicitly earnings releases (ER). Since it's not a formal financial report, RNS is the most appropriate fallback.
2012-01-12 English
Bilan semestriel du contrat de liquidité
Capital/Financing Update Classification · 99% confidence The document is titled "METabolic EXplorer : Bilan semestriel du contrat de liquidité" (METabolic EXplorer: Semi-annual balance sheet of the liquidity contract). It details the holdings (shares and cash) in a liquidity account as of December 31, 2011, compared to June 30, 2011. This is a specific financial update related to market making or share stabilization activities, which is not explicitly covered by the main definitions like 10-K, ER, or IR. It is a periodic report on a specific financial arrangement. Given the options, it is a specialized financial disclosure. Since it is a periodic report on a specific financial mechanism (liquidity contract balance), and not a general earnings release (ER) or comprehensive interim report (IR), it fits best under the general regulatory/financial disclosure category, or potentially a specialized financing update. However, it is a formal report on a specific financial instrument/contract balance. It is not a dividend announcement (DIV), capital change (CAP/SHA), or director dealing (DIRS). Because it is a formal, periodic report on a specific financial arrangement, and does not fit the other specific financial codes, it is classified as a general Regulatory Filing (RNS) as a fallback for specialized, non-standard disclosures, although it shares characteristics with financing updates.
2012-01-11 French

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.